Calif First National (CFNB) 14.61 $CFNB California First

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Calif First National (CFNB) 14.61 $CFNB

California First National posts 2Q profit
Automated Insights - Fri Jan 29, 4:54PM CST
IRVINE, Calif. (AP) _ California First National Bancorp (CFNB) on Friday reported fiscal second-quarter profit of $1.6 million.
CFNB: 14.61 (+0.21)

CFNB Reports Lower Fourth Quarter Net Earnings of $1.4 Million
BusinessWire - Wed Jul 29, 6:00AM CDT
California First National Bancorp (NASDAQ: CFNB) ("Company" net earnings for the fourth quarter ended June 30, 2015 of $1.4 million were 26% below net earnings of $1.8 million for the fourth quarter 2014. For fiscal year ended June 30, 2015, net earnings of $9.1 million were 28% above $7.05 million reported for fiscal 2014. Diluted earnings per share (EPS) for fourth quarter 2015 of $0.13 per share were down 26% from $0.18 for the fourth quarter of the prior year, while EPS of $0.87 for fiscal 2015 were up 28% from $0.67 per share for fiscal 2014.
CFNB: 14.61 (+0.21)

Amplicon introduces 4th generation Ventrix and Impact-R rackmount industrial PCs
M2 - Fri Jul 17, 9:56AM CDT
Amplicon proudly introduce the amazing power of the Intel® Core(TM) 4th generation processor family, unleashing incredible processing power with low power consumption, lower thermal characteristics, and rich I/O.
CFNB: 14.61 (+0.21)

Fluxion Biosciences and Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow for Somatic Mutation Detection From Liquid Biopsy Samples
BusinessWire - Thu May 28, 8:00AM CDT
In advance of the 2015 American Society of Clinical Oncology Annual meeting, Fluxion Biosciences, Inc. and Swift Biosciences, Inc. announced a new workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The jointly-developed workflow utilizes Fluxion's IsoFlux(TM) System for circulating tumor cell (CTC) enrichment and Swift's Accel-Amplicon(TM) technology for high sensitivity variant detection using low starting inputs.
CFNB: 14.61 (+0.21)

CFNB Third Quarter Net Earnings Up 41%
BusinessWire - Tue Apr 21, 5:48PM CDT
California First National Bancorp (NASDAQ:CFNB) ("CalFirst Bancorp" today announced that net earnings for the third quarter ended March 31, 2015 of $1.7 million increased 41% from $1.2 million for the third quarter of fiscal 2014. For the nine months ended March 31, 2015, net earnings of $7.7 million were up 48% from $5.2 million reported for the first nine months of fiscal 2014. Diluted earnings per share for the third quarter of fiscal 2015 of $0.16 per share were up 41% from $0.11 per share for the third quarter of fiscal 2014, while diluted earnings per share for the first nine months of fiscal 2015 of $0.74 were 48% above $0.50 per share reported for the same period of the prior fiscal year.
CFNB: 14.61 (+0.21)

Nasdaq stocks posting largest volume decreases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
DNBF: 23.75 (unch), PPSI: 5.05 (-0.30), OFED: 19.75 (-0.11), SSFN: 6.54 (+0.03), NVSL: 10.95 (-0.02), UNTY: 12.99 (+0.18), CFNB: 14.61 (+0.21), CWAY: 12.44 (+0.09), PSBH: 10.25 (-0.05), MLVF: 15.10 (-0.52), SOCB: 14.02 (+0.16), ITIC: 96.16 (+3.21), MGYR: 9.90 (-0.20)

Amplicon launches brand new expandable rugged tower PC
M2 - Thu Feb 12, 9:35AM CST
The new Impact-T 400 brings power of expansion to the Amplicon embedded family in a tower chassis. Packaged in a lightweight aluminium chassis, designed for optimal heat dissipation, the Impact-T 400 has been designed with card expansion at its heart.
CFNB: 14.61 (+0.21)

A Primer On Financial Sector Players: Research Reports on Bryn Mawr Bank, BSB Bancorp, C&F, Calamos, and CalFirst
PR Newswire - Wed Feb 11, 7:54AM CST
Editor Note: For more information about this release, please scroll to bottom.
CLMS: 7.21 (+0.21), BLMT: 23.39 (+0.44), CFNB: 14.61 (+0.21), CFFI: 46.74 (+1.26), BMTC: 28.84 (+0.50)

CFNB Second Quarter Earnings Up 63%
BusinessWire - Wed Jan 21, 6:00AM CST
California First National Bancorp (NASDAQ: CFNB)("CalFirst Bancorp" today announced net earnings of $3.6 million for the second quarter ended December 31, 2014, a 63% increase from net earnings of $2.2 million for the second quarter of fiscal 2014. For the six months ended December 31, 2014, net earnings increased 50% to $6.0 million from $4.0 million for the first six months of fiscal 2014. Diluted earnings per share for the second quarter of fiscal 2015 of $0.34 were up 63% from $0.21 for the second quarter of fiscal 2014, while diluted earnings per share of $0.58 for the first six months of fiscal 2015 also increased 50% from $0.38 per share for the same period of fiscal 2014.
CFNB: 14.61 (+0.21)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 364

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 160

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading